An Investigator Sponsored Phase 1a/1b Trial of Selinexor in Combination With Irinotecan in Patients With Adenocarcinoma of Stomach and Distal Esophagus

Trial Profile

An Investigator Sponsored Phase 1a/1b Trial of Selinexor in Combination With Irinotecan in Patients With Adenocarcinoma of Stomach and Distal Esophagus

Discontinued
Phase of Trial: Phase I

Latest Information Update: 30 Jan 2016

At a glance

  • Drugs Selinexor (Primary) ; Irinotecan
  • Indications Gastric cancer; Oesophageal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Jan 2016 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
    • 07 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 08 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top